Jaykay Enterprises Limited has informed the Exchange regarding a press release dated May 27, 2026.
JAYKAY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jaykay Enterprises reported exceptional Q4 FY2025-26 results with total income of ₹69.78 crore, up 322% from ₹16.53 crore in Q4 FY2024-25, and PAT of ₹179.82 crore versus a loss of ₹4.41 crore in the same quarter last year. For the full year FY2025-26, total income surged 185% to ₹282.30 crore from ₹98.94 crore, with EBITDA growing 274% to ₹66.89 crore and PAT at ₹215.65 crore. The company noted exceptional items including ₹262.66 crore from revaluation of its investment in JK Urbanscapes Developers Ltd. Key developments include securing defence orders from BrahMos, HAL, BEL, and BDL, completing the Cherlapally facility expansion, progressing the Devanahalli manufacturing plant, and acquiring Patange Industries for defence precision manufacturing. The company also launched Patient Specific Implants commercially and deployed its JIVA AI platform in US and European markets.
The strong multi-fold revenue and profit growth reflects the company's transition from component supplier to high-value technology-driven manufacturing, with visible progress in defence/aerospace capabilities and new business acquisitions. The exceptional income item from investment revaluation significantly boosts PAT, though investors should note the one-time nature of this gain. The stock could see positive sentiment given the defence sector momentum and expanding order book.